Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...
IEEE

A Novel GA-PSO-SVM Model for Compound Fault Diagnosis in Gearboxes With Limited Data

Abstract: Accurately diagnosing compound faults in gearboxes, where multiple fault modes co-occur, poses significant challenges, particularly when labeled training data is limited. This article ...
The Nation (PK) on MSN

PSO strengthens fuel supply chain to ensure Pakistan's energy security

Pakistan State Oil (PSO) has proactively optimized its operations in response to the evolving geopolitical environment, to ...